On October 26, 2017 Juniper Pharmaceuticals (Nasdaq: JNP) (“Juniper” or the “Company”), reported that it will hold a conference call on November 2, 2017, to discuss the financial results for the third quarter ended September 30, 2017, as follows (Press release, Juniper Pharmaceuticals, OCT 26, 2017, View Source [SID1234521214]):

Date:
Thursday, November 2, 2017
Time:
4:30 p.m.
Dial-in numbers:
Toll free: (1-866-374-4635) (U.S.), (1-855-669-9657) (Canada), or

International: (1-412-902-4218)

Audio webcast (live & archive): www.juniperpharma.com, under ‘Investors’ or click here.

The teleconference replay will be available approximately one hour after completion through Thursday, November 9, 2017, at 1-877-344-7529 (U.S.), 1-855-669-9658 (Canada) or 1-412-317-0088 (International). The replay access code is 10113476.

The archived webcast will be available for one year via the aforementioned URLs.